beta-D-Galp-(1->2)-alpha-D-Glcp-(1<->1)-alpha-D-Glcp

Term ID

CHEBI:146891

Synonyms

(2S,3R,4S,5R,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-D-gluco-hexopyranosyl beta-D-galacto-hexopyranosyl-(1->2)-alpha-D-gluco-hexopyranoside
alpha-D-glucopyranosyl beta-D-galactopyranosyl-(1->2)-alpha-D-glucopyranoside
Gal(b1-2)Glc(a1-1a)Glc

Definition

A trisaccharide that is β-D-galactopyranosyl-(1→2)-α-D-glucopyranoside in which the anomeric hydroxy group has been converted into the corresponding α-D-glucopyranosyl derivative.

References

glygen:G05921XS
glytoucan:G05921XS
kegg.glycan:G08969

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->2)-alpha-D-Glcp-(1<->1)-alpha-D-Glcp

Phenotype where environments contain beta-D-Galp-(1->2)-alpha-D-Glcp-(1<->1)-alpha-D-Glcp

Phenotype modified by environments containing beta-D-Galp-(1->2)-alpha-D-Glcp-(1<->1)-alpha-D-Glcp

Phenotype affecting beta-D-Galp-(1->2)-alpha-D-Glcp-(1<->1)-alpha-D-Glcp

Human Disease Model